| D36 | HIV funding and access to treatment in sub-Saharan Africa | E-poster | Impact of donor agencies’ policies and international financing initiatives |
| B27 | HIV immune reconstitution inflammatory response syndrome and the risk of adverse pregnancy-fetal outcomes among ART naïve women aged 20-49 years in selected public hospitals, Nairobi, Kenya | On-demand oral abstract session | Immune reconstitution disorders and immune reconstitution inflammatory syndrome |
| C18 | HIV incidence in postpartum period: findings from Uganda's national PMTCT Impact Evaluation (PMTCT-IE) 2017-2019 | E-poster | Novel studies to measure HIV incidence |
| B62 | HIV minority resistance variants partially explain genotypic-phenotypic discordance | E-poster | ARV management strategies in paediatric and adolescent populations |
| A17 | HIV modifies the m6A and m5C epitranscriptomic landscape of the host cell | On-demand oral abstract session | Host cellular factors and latency |
| C15 | HIV pattern and cascade of care among incarcerated people in Iran: Findings of three consecutive national bio-behavioral surveillance surveys | On-demand oral abstract session | Surveillance in key population groups |
| C35 | HIV pre-exposure prophylaxis (PrEP) care in a LGBTQ community-based sexual health and wellness clinic after COVID-19 restrictions | E-poster | HIV prevention adaptations during COVID-19 |
| C27 | HIV pre-exposure prophylaxis amongst most-at-risk populations in Cameroon: lessons learnt from the CHAMP project | E-poster | PrEP |
| C25 | HIV Prevention in COVID-19 lockdown: The impact of suspending VMMC in SA and the subsequent effects on HIV transmission dynamics | E-poster | Male circumcision |
| C27 | HIV recent infection test-based incidence as a counter-factual for new PrEP trials | E-poster | PrEP |